Military medical revolution (2012)

In an effort to describe periods of profound change in military organization and practice, historians have given us a unique way to classify and describe these developments in a historical perspective. The concept describes advances in the art and practice of combat arms resulting in profound change as “military revolutions” accompanied by supporting “revolutions in military affairs.” Military Revolutions Murray and Knox1 equated military revolutions to “earthquakes.” These earthquakes forced a fundamental change in society and a state, and the state consequently altered the way it created and projected military power. Murray and Knox recognize five major military revolutions that have had that impact on Western history: the 17th century creation of the modern state and modern military institutions; the French Revolution; the Industrial Revolution; World War I; and, most recently, nuclear weapons and ballistic missile delivery systems. This concept of military revolutions has also carried into the field of military medicine. Military Medical Revolutions Throughout recorded history, there have been several profound medical enlightenments that can be seen as revolutions or “earthquakes” in the management of combat wounded (Table 1). With incremental and cumulative advances, the concept of the military medical revolution (MMR) can be defined by the amalgamation of the multiple and progressively complex medical advances defined by the term revolution in military medical affairs (RMMA). RMMAs supporting the overall MMR occurred during the American Civil War, World War I, World War II, the Korean War, and the Vietnam War.TABLE 1: MMR and Supporting RMMAsMMRs in the past two centuries have been born of multiple advances that form the underpinnings of a true revolution. The American Civil, Crimean, and Franco-Prussian Wars saw the nascent practice of battlefield anesthesia, system of multiple hospitals, nursing care, and antisepsis that, in the aggregate, would meet the definition of the first MMR supported by multiple RMMAs. Subsequent examples of RMMAs supporting the overall MMR (Fig. 1) occurred during the World War I/World War II era and during the Korean/Vietnam War era.2–5Figure 1: Concept of MMR and RMMAs.Many advances in combat casualty care from the point of injury to rehabilitation in the continental United States were made during the overseas contingency operations in Iraq and Afghanistan within the decade from 2001 to 2011. The prehospital advances categorized as individual RMMAs are shown (Table 2). Many of these RMMAs were directly translated from civilian trauma practice, whereas others were developed by the military and subsequently translated into the civilian injury care environment.Table 2: RMMAs, 2001 to 2011 Overseas Contingency Operations in Afghanistan and IraqThe RMMAs that occurred during the last 10 years of combat casualty care in the realm of prehospital care are detailed in the following sections. PREHOSPITAL CARE Tourniquets For two millennia, tourniquets were the most controversial topic in first aid,6,7 but now they are not—they are an essential first aid tool on the battlefield. This change from controversial to essential was an RMMA, a new beginning for an old device. As recently as the war in Vietnam, tourniquet use was sporadic as soldiers were trained that tourniquets were a “last resort” while some military physicians strongly advocated for their use. Neither point nor counterpoint had adequate data to substantiate its claim and published literature largely relied on opinion. When US forces went to war in Afghanistan in 2001, with the exceptions of a few Special Operation Forces (SOF) units, they went without tactical tourniquets and were trained not to use tourniquets. In 2001, at the onset of hostilities in Afghanistan, none of the other military services had service-wide tourniquet policies or programs in place. As the United States and her coalition partners suffered losses in Afghanistan, attention was redirected to deaths from potentially survivable injuries, especially extremity hemorrhage. Similar to the Afghanistan operational experience, in March 2003 on entry into Iraq, some of the first US military deaths were soldiers who exsanguinated from isolated limb injuries. Subsequently, the US Army Institute of Surgical Research spearheaded efforts to assess tourniquet options that met specific criteria for deployment.6 In 2004, with growing clinical and testing experience, military medical experts recommended that modern tourniquets be fielded widely to the deployed forces.6 The US Special Operations Command (USSOCOM) was the first command to mandate tourniquets for its deploying combatants (USSOCOM Chief of Staff, Tactical Combat Casualty Care Training and Equipment e-mail message, March 5, 2005). By 2006, tourniquet use on the battlefield had become ubiquitous. The combat support hospital at Ibn Sina Hospital (Baghdad, Iraq) was a central hub of medical care in Iraq. At Ibn Sina Hospital, investigators documented the lifesaving impact of prehospital tourniquets with more precision than had ever been accomplished in previous studies. In a comprehensive approach, prehospital emergency tourniquets saved lives when they were used rapidly and correctly in the setting of life-threatening extremity hemorrhage. Comparing data on tourniquet use before- versus after-shock onset, placement prehospital versus hospital, and no tourniquet use versus tourniquet use painted a clear picture of major survival benefit with powerful, scalable, temporal, and physiologically based associations.7 Modern tourniquet use has had a far reaching impact and has been responsible for saving an estimated one to two thousand US military lives in Operation Enduring Freedom and Operation Iraqi Freedom. Tourniquets are now perceived as an essential tool for implementing best practice care of war casualties. After aggressive reintroduction, use of the battlefield tourniquet has been the signature lifesaving prehospital intervention of the wars in Iraq and Afghanistan and represents a profound change in prehospital combat casualty care. Hemostatic Dressings Hemorrhage remains the leading cause of potentially preventable death among combat casualties. The urgency of this problem led to a revolution in the development and use of battlefield hemostatic dressings. For more 2,000 years, gauze dressings have been used to staunch bleeding. In efforts to improve on this ancient hemostatic dressing, military laboratories developed test and evaluation programs for these products resulting in improved dressings fielded expeditiously to treat life-threatening hemorrhage. First Generation of Hemostatic Dressings The US Army’s early effort to improve hemostatic dressings focused on the dry fibrin sealant dressing.8 This dressing was briefly deployed to SOF medics in Iraq but was withdrawn because of regulatory challenges. This agent was replaced with the HemCon bandage (HC). These dressings were widely distributed among US Army forces for use on the battlefield. HC is made of freeze-dried chitosan and works by tissue adhesion and interaction of its positively charged chitosan with negatively charged blood cells.9 Concurrent with HC fielding by the US Army, QuikClot, a granular hemostatic agent, was deployed by the US Navy and the US Marine Corps. Experimental studies demonstrated efficacy against venous bleeding10 or mixed arterial and venous bleeding (better than gauze or no treatment at all);11 however, it was ineffective against a more severe arterial bleeding.12 The proposed mechanism of this mineral-based (zeolite) agent is through absorbance of water and concentration of blood clotting proteins and cells resulting in hemostasis.13 The significant heat generated as a result of interaction of zeolite with blood/water may have also contributed to the hemostatic function, but the heat generated was the source of safety concerns and documented burns.10,14 Second Generation of Hemostatic Dressings The effort to find better hemostatic products and support development of more promising agents continued, and by 2007, a number of new topical hemostatic agents had received clearance from the US Food and Drug Administration (FDA) and were subjected to comprehensive studies in two independent military laboratories.15–18 Based on an analysis of data from animal models designed to evaluate both safety and efficacy, in 2008, Combat Gauze was recommended by the Committee on Tactical Combat Casualty Care for distribution to US forces. Combat Gauze has now been widely distributed and essentially has replaced the previously deployed hemostatic agents (HC and QuikClot). Hypothermia Prevention Hypothermia, defined as a core body temperature of 35°C or less, has been associated with greater resuscitation fluid requirements, prolonged clotting times, and other dysfunctions of the hemostatic process, independent of the development of acidosis following traumatic injury.19–22 For the military, the hypothermia incidence rate was 6.0%, and hypothermic casualties had a significantly higher mortality rate.23 Efforts to prevent hypothermia onset are a challenge in military prehospital settings (US Army Levels I and II), and hypothermia prevention has become a high priority, leading to its inclusion in the teachings of Tactical Combat Casualty Care (TCCC). The wool blanket has a long history but has recently been shown to provide little benefit in preventing heat loss.24 The consequent innovation was the development of the Hypothermia Prevention and Management Kit (HPMK) to provide warmth for several hours without an external power source. The HPMK includes a reflective blanket with an incorporated hood and four built-in chemical heating elements that are more effective in maintaining body temperature.24 When the HPMK was combined with a targeted training program and diligent process improvement initiative, the US Military was able to significantly reduce the incidence of hypothermia in combat casualties. Prehospital Care in the United Kingdom Defence Medical Service The rapid tactical evacuation (TACEVAC) of military casualties from the battlefield to higher echelons of care is a crucial mission to preserve the life of casualties in critical conditions. TACEVAC includes evacuation by both designated medical (MEDEVAC) mobility assets and casualty evacuation (CASEVAC) by tactical mobility platforms. Helicopter TACEVAC enables relatively rapid, long-range evacuations independent of ground transportation infrastructure. Recognition that severely injured patients can significantly benefit from lifesaving interventions such as damage-control resuscitation (DCR), advanced airway maneuvers, and thoracic trauma management before arrival at a Role 2 facility led to the development of the Medical Emergency Response Team (MERT), a revolution in military medical evacuation (Fig. 2).Figure 2: Medical Emergency Response Team.The use of physicians and nurses in aeromedical evacuation has its roots in the Incident Response Team used in Iraq, which included an emergency nurse and a doctor when required. This concept was expanded in 2006 in response to the potential, long evacuation times of casualties inherent to UK Armed Forces operations in Helmand Province in southern Afghanistan.25 The MERT consists of a critical care skilled registered general nurse with emergency medicine background and a paramedic.26 This team is equipped and trained to provide battlefield advanced trauma life support interventions. This basic MERT format is almost always “enhanced” (MERT-E) with the inclusion of a second paramedic and a senior physician (consultant or very senior trainee) drawn from the emergency medicine or intensive care cadre, enabling physician-led interventions.27 The MERT is capable of deploying on a variety of platforms, but in Afghanistan, MERT uses a CH-47 Chinook. The CH-47 is capable of carrying up to 8 stretcher cases or 20 ambulatory casualties, and in addition to the MERT, the CH-47 also carries four soldiers who provide force protection and can assist the MERT with basic procedures. The underlying philosophy is the concept of early critical care that dovetails into the UK Defence Medical Service trauma system paradigm of DCR. The practices of the MERT that facilitate the delivery of this medical doctrine for catastrophic bleeding, airway protection, thoracic trauma management, and other clinical and nonclinical aspects are as follows. Catastrophic Bleeding In addition to hemostatic advanced dressings and tourniquets, early hemostatic resuscitation with prehospital blood products is a key component of DCR. The MERT-E carries a cold box containing 4 U of O-positive packed red blood cells (PRBCs) and 4 U of fresh frozen plasma (FFP), and any dispensed blood products are given through a fluid warmer. The decision to transfuse is physician led and is intended for critically shocked patients who are considered salvageable. These are difficult decisions that require experience and injury pattern recognition—a theme throughout MERT practice. In parallel with the administration of prehospital blood is the option to administer the antifibrinolytic drug tranexamic acid.28 Airway Protection A skill common to all physicians deploying on the MERT-E is that they must be proficient at airway assessment and competent to definitively secure an airway if required. Generally, this takes the form of a rapid sequence induction using direct laryngoscopy. Several rescue devices are also available as alternatives or for use in a failed intubation such as supraglottic airways, optical laryngoscopes, and cricothyroidotomy. Thoracic Trauma Management A large supply of oxygen is carried on the CH-47. This allows the administration of 15 L per minute for all casualties carried if required. Apart from application of a chest seal, the main thoracic intervention practiced on the MERT and MERT-E is the thoracostomy to decompress the chest. A more radical approach to patients in extremis is to perform a prehospital thoracotomy with the aim of releasing a tamponade, controlling hemorrhage, and/or controlling the aorta.29 Although this facility exists on the MERT-E, few have been performed, with no survivors to date. Prehospital Resuscitation with Freeze-Dried Plasma Although the field of transfusion medicine was essentially born on the battlefields of World War I and freeze-dried plasma (FDP) was developed early in the 1940s and extensively used by US Forces during World War II, hemorrhage resuscitation practices strayed widely from the experience of these conflicts, and it is only now that we are developing the scientific evidence to establish prehospital FDP use as an RMMA. Crystalloid was widely used to treat hemorrhagic shock resuscitation during the Vietnam War, and this practice became codified in the Advanced Trauma Life Support teachings developed for civilian trauma systems during the 1970s and 1980s. By the 1990s, it was recognized that this practice had caused a virtual epidemic of dilutional coagulopathy and abdominal compartment syndrome in severely injured trauma patients who were aggressively resuscitated. Early US military experience in Somalia, Afghanistan, and Iraq revitalized the concept of treating hemorrhage with plasma to preserve coagulation system function and treat the acute coagulopathy of trauma as well as to replace physiologic buffers and treat acidosis. The requirement to keep plasma frozen presents obvious logistical problems for operational military use, particularly during operations in remote and austere environments. An FDP product that would be stable at ambient temperatures and that could be reconstituted for use on demand would permit delivery of plasma to bleeding casualties in the field and reduce suboptimal treatment with crystalloids and colloids. The US military is currently developing such products with commercial partners. While these programs advance toward the goal of approval from the FDA, the USSOCOM has partnered with the French military to field French-made FDP under an expanded access investigational new drug protocol. The French FDP will be used in far-forward operations by SOF medical personnel to treat critically wounded casualties. This French product represents the first step in the long march to restoring FDP to the US trauma care armamentarium after a decades-long hiatus. This concept has been reviewed and endorsed by the Defense Health Board. It is anticipated that this nascent RMMA will result in improved battlefield care and pave the way for a transformation of civilian trauma resuscitation. Transformations in Military Blood Banking The wars in Afghanistan and Iraq are the first major conflicts fought by the United States in the modern era of transfusion medicine. At the beginning of the conflicts in Afghanistan and Iraq, the standard blood products available to deployed US military units were PRBCs and FFP. Cryoprecipitate and platelets were unavailable. Military doctrine allowed for emergency use of fresh whole blood (FWB) in combat settings if components were unavailable or if it was thought that a patient would benefit from FWB (e.g., owing to a deficiency of platelets). In 2004, apheresis platelets were collected in Balad, Iraq, for use in combat trauma. The Afghanistan/Iraq war saw the development of the concept of DCR.30 This led to a significant increase in FFP use and the unprecedented distribution of FFP to the Role 2/Forward Surgical Team setting. Positive results from analyses of platelet transfusion led the Army Surgeon General to mandate availability of apheresis platelets in every Role 3/combat support hospital setting in 2008.31 US military blood banking practice thus adapted to support the implementation of 1:1:1 (platelet/FFP/PRBC) transfusion across the vast Central Command area of operations. In addition, Armed Services Blood Program Office worked relentlessly to speed delivery of PRBC units to theater so that the average age of such units arriving in theater continued to drop, such that, in 2012 the average age of PRBC units transfused in Afghanistan was 21 days. Interestingly, more than 8,000 U of FWB have been transfused, with data showing improved outcomes when compared with components.32 Finally, important strides to improve transfusion safety were made for recipients of FWB with the fielding of rapid tests for human immunodeficiency virus, hepatitis B virus, and hepatitis C In an analysis of US casualties who of had potentially survivable injuries. that in the hemorrhage mechanism of potentially survivable had bleeding as the mechanism of In 2008, made a that which was used in for hemorrhage could be used prehospital by medics to hemorrhage as a of tourniquets. with extremity tourniquets, tourniquets a greater are more and more complex and more associated of greater than other The bleeding is and the intervention is more whereas the are to In response to this the Medical Research and Command a For on March The Combat Medical was developed in The was by the for difficult on the battlefield in and in the Committee on Tactical Combat Casualty Care to the and the was by the Defense Health in 2011 As the first devices are fielded in Afghanistan, to assess these devices in theater and in studies. care into based on the tactical attention is focused on the As the is to the best medical care for the casualties. This paradigm of field care in tactical settings is very from civilian Tactical and have a profound impact on trauma care on the battlefield. medicine can be These of prehospital care on the battlefield have been by the of the of and have improved combat casualty was responsible for the concept and of this of the and and contributed a with in their area of and reviewed the In addition, and of the for the support and for the was received from the of or Medical